Articles Tagged With: FDA
-
Herpes Vaccine Could Be Available by 2030
Early efforts to produce a protein-based vaccine for herpes failed. But a new mRNA approach has outperformed the efficacy of the past vaccines in preclinical trials and is expected to be introduced in clinical trials in the second half of 2022, investigators say. This new approach for a prophylactic genital herpes vaccine showed great promise in early studies.
-
Can New Antivirals Against COVID-19 Solve Staff Shortages?
One answer to the healthcare staffing shortages could be a newly developed antiviral that works against SARS-CoV-2 much like influenza antivirals negate the symptoms of flu. -
FDA Approves Telemedicine Abortion; Canadian Study Demonstrates Safety
Research shows that mifepristone can be treated as a normal prescription without compromising safety and risking complications. -
FDA Authorizes Oral Antiviral for COVID-19
Clinicians add another valuable tool to their armamentarium.
-
First Injectable Pre-Exposure Prophylaxis Receives FDA Approval
Researchers hope this long-acting solution every will boost PrEP adherence rates among those at risk for contracting HIV.
-
FDA: Eye Injuries Increasing Because of Alcohol Hand Rubs
Although a key infection control intervention, the ubiquitous presence of alcohol-based hand hygiene dispensers has led to an increase in people reporting severe eye irritations and injuries.
-
AAN Offers Ethical Guidance on Alzheimer’s Drug
Neurology experts issue caution on costs, side effects regarding the approved-but-controversial Aduhelm.
-
Pandemic Affected Family Planning, Abortions, Contraceptive Counseling
New research highlights the challenges many reproductive health providers and family planning clinics faced during the COVID-19 pandemic. These include discontinuation of services, such as placing long-acting reversible contraception and prescribing emergency contraceptive pills in advance. -
Cost to Treat U.S. Patients with Rare Diseases Likely Underestimated
NIH, FDA, other groups form consortium to speed gene therapy development.
-
Is the Suicidality Class Warning Warranted for Antiseizure Medications?
This study reports data that refutes the U.S. Food and Drug Administration’s class warning regarding suicidality risk in patients with epilepsy who are taking the newer antiepileptics, approved since 2008. The class warning should be reconsidered.